PressDECEMBER 4, 2025Mission Bio Announces Results Leveraging Tapestri Single Cell Multi-Omics Platform for Exploratory Biomarker Analysis in Myeloproliferative Neoplasms (MPNs) to be Presented at ASH 2025
PressNOVEMBER 20, 2025Mission Bio Announces Single-Cell Targeted DNA + RNA Assay at ASH 2025, Closing the Mutation-to-Expression Gap in Cancer Research
PressOCTOBER 9, 2025Mission Bio Appoints Dr. Zivjena Vucetic as Chief Medical Officer to Lead Clinical Adoption and Biopharma Partnerships
PressAUGUST 5, 2025Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion
PressJUNE 5, 2025Mission Bio Unveils Industry-First Single-Cell Genotype and Targeted Gene Expression Solution Aimed at Derisking Cancer Drug Clinical Development
PressMAY 21, 2025Nature Publication Shows Mission Bio's Tapestri® Platform Enables Real-Time, Single-Cell Tracking of Precancerous Clones Using Natural Epigenetic Markers
NewsMAY 7, 2025Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis
PressMAY 6, 2025Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis
PressDECEMBER 5, 2024Mission Bio Showcases Critical Insights Into Multiple Myeloma, AML MRD, CAR-T Safety & Integrated Single-Cell DNA and Fusion Profiling at the 2024 ASH Annual Meeting
PressDECEMBER 2, 2024Mission Bio Partners With Top Researchers From University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma Patients
PressSEPTEMBER 26, 2024Mission Bio Launches Innovative Single-cell Genome Integrity Solution to Measure Whole Genome Copy Number Variation in Advanced Therapies and Tumor Samples
PressAUGUST 20, 2024Mission Bio’s Tapestri Platform Utilized in Development of Advancements in Gene-Edited T-Cell Therapy
PressJULY 11, 2024Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion
PressJUNE 4, 2024Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform Translational Research and Therapy Development
